Patent Law Weblog
recent posts
- USPTO Moves to Protect Design Rights for Digital Innovations
- Judicial Conduct and Disability Committee Has Its Say, Denies Judge Newman’s Latest Request for Review
- PTAB Issues Judgment on Priority in CRISPR Interference
- Parties File Supplemental Priority Statements in CRISPR Interference
- Why the Alice Test is Stupid, Part V: The Goalposts Keep Moving
about
Month: May 2013
-
By Ann Palma — About Court Report Supplement: Periodically, we will report on biotech and pharma cases that were inadvertently omitted from our Court Report column. Tawnsaura Group, LLC v. Direct Digital, LLC8:13-cv-00004; filed January 2, 2013 in the Central District of California Infringement of U.S. Patent Nos. 5,874,471 ("Orthomolecular medical use of L-Citrulline for…
-
By Michael Borella — On May 10, the Federal Circuit handed down a much anticipated en banc ruling regarding the patent eligibility of computer-implemented inventions under 35 U.S.C. § 101. In a per curiam opinion that is perhaps the most important § 101 jurisprudence since the Supreme Court's Bilski v. Kappos and Mayo v. Prometheus…
-
By Kevin E. Noonan — The biggest concern of the biotechnology industry caused by the impending Supreme Court decision in the AMP v. Myriad Genetics case is the threat to existing patents having claims to isolated human DNA (and the DNA from other species) that a negative decision from the Court could raise. Patent protection…
-
By Donald Zuhn — Today, in Bowman v. Monsanto Co., the Supreme Court determined that the doctrine of patent exhaustion did not permit a farmer who buys patented seeds to reproduce them through planting and harvesting without the patent holder's permission, affirming the Federal Circuit's decision that such activities amount to the creation of a…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Bristol-Myers Squibb Co. v. Genentech, Inc. et al.3:13-cv-02045; filed May 3, 2013 in the Northern District of California • Plaintiff: Bristol-Myers Squibb Co.• Defendants: Genentech, Inc.; City of Hope Declaratory judgment of invalidity, unenforceability, and…
-
May 13-14, 2013 – Generics and Patent Strategies (SMi) – London, UK May 14, 2013 – Forum on Pharma & Biotech Collaborations (C5 (UK)) – Frankfurt, Germany May 14-16, 2013 – Fundamentals of Patent Prosecution 2013: A Boot Camp for Claim Drafting & Amendment Writing (Practising Law Institute) – Chicago, IL May 15-16, 2013 –…
-
McDonnell Boehnen Hulbert & Berghoff LLP will be offering a live webinar entitled "Harmonization of USPTO Ethical Standards in the Post-AIA Era" on May 30, 2013 from 10:00 am to 11:15 am (CT). MBHB attorney and Patent Docs contributor Dr. Andrew Williams will moderate a presentation by Director William R. Covey, Deputy General Counsel and…
-
The Benjamin N. Cardozo School of Law will host its first Patent Law Summer Intensive for students and practitioners on July 15-19, 2013. The week-long program will have two components — participants may enroll in one or both components. The morning component will be an intensive 15-hour course called Introduction to Patent Law which will…
-
Intellectual Asset Management (IAM) magazine will be hosting its 6th annual IP Business Congress on June 9-11, 2013 in Boston, MA. The IP Business Congress brings together senior thought leaders who specialize in the business of IP to come together to discuss cutting-edge issues around IP value creation. Among the plenary and breakout sessions being…
-
By Donald Zuhn — On March 22, Senators Max Baucus (D-MT) and Orrin Hatch (R-UT), the Chairman and Ranking Member, respectively, of the Senate Committee on Finance, sent a letter to Ambassador Demetrios Marantis, the Acting United States Trade Representative, "to emphasize the importance of achieving a comprehensive, high-standard intellectual property chapter" as negotiations on the…
Patent Docs 